126 related articles for article (PubMed ID: 3533271)
1. L-5-hydroxytryptophan versus placebo in childhood migraine prophylaxis: a double-blind crossover study.
Santucci M; Cortelli P; Rossi PG; Baruzzi A; Sacquegna T
Cephalalgia; 1986 Sep; 6(3):155-7. PubMed ID: 3533271
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
3. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.
Sorge F; De Simone R; Marano E; Nolano M; Orefice G; Carrieri P
Cephalalgia; 1988 Mar; 8(1):1-6. PubMed ID: 3282670
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
5. Flunarizine v. placebo in childhood migraine. A double-blind study.
Sorge F; Marano E
Cephalalgia; 1985 May; 5 Suppl 2():145-8. PubMed ID: 2861907
[TBL] [Abstract][Full Text] [Related]
6. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
7. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
8. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
Klapper J
Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
[TBL] [Abstract][Full Text] [Related]
9. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
Brandes JL; Visser WH; Farmer MV; Schuhl AL; Malbecq W; Vrijens F; Lines CR; Reines SA;
Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of cinnarizine in the prophylaxis of migraine in children: a double-blind placebo-controlled randomized trial.
Ashrafi MR; Salehi S; Malamiri RA; Heidari M; Hosseini SA; Samiei M; Tavasoli AR; Togha M
Pediatr Neurol; 2014 Oct; 51(4):503-8. PubMed ID: 25023977
[TBL] [Abstract][Full Text] [Related]
11. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study.
Hagen K; Brenner E; Linde M; Gravdahl GB; Tronvik EA; Engstrøm M; Sonnewald U; Helde G; Stovner LJ; Sand T
Cephalalgia; 2015 Oct; 35(11):987-95. PubMed ID: 25601916
[TBL] [Abstract][Full Text] [Related]
13. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial.
Tfelt-Hansen P; Standnes B; Kangasneimi P; Hakkarainen H; Olesen J
Acta Neurol Scand; 1984 Jan; 69(1):1-8. PubMed ID: 6367336
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study.
Bigal ME; Edvinsson L; Rapoport AM; Lipton RB; Spierings EL; Diener HC; Burstein R; Loupe PS; Ma Y; Yang R; Silberstein SD
Lancet Neurol; 2015 Nov; 14(11):1091-100. PubMed ID: 26432181
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine.
Slater SK; Nelson TD; Kabbouche MA; LeCates SL; Horn P; Segers A; Manning P; Powers SW; Hershey AD
Cephalalgia; 2011 Jun; 31(8):897-905. PubMed ID: 21586650
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
[TBL] [Abstract][Full Text] [Related]
20. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
